GAINESVILLE, Fla.--(BUSINESS WIRE)-- IrriMax® Corporation, a leader in the development of innovative irrigation systems, announced today it has been awarded a supplier contract with the Premier healthcare alliance, effective February 1, 2012, for its IrriSept® wound debridement and cleansing system. The IrriSept system is the first and only FDA-cleared irrigation device containing Chlorhexidine Gluconate (CHG), finally providing an alternative to traditional saline irrigation. IrriSept is packaged and available for use in surgical and non-surgical environments.
“We are very pleased to be associated with an organization like Premier, particularly given its emphasis on patient safety,” explains Gareth Clarke, CEO of IrriMax Corp. “IrriSept offers Premier members the only irrigation system containing a 0.05 percent concentration of CHG, shown effective in laboratory testing against a variety of bacteria and fungi, including Staph and MRSA1,2,” shares Clarke. “IrriSept is designed for use on all wounds, and examples include surgical wounds (as a final rinse before closure), skin and soft tissue infections, abscesses, deep traumatic wounds, lacerations and puncture wounds. Our goals are to improve patient outcomes by helping resolve and/or prevent infections, and to increase the safety of healthcare professionals.”
About the Premier Healthcare Alliance, Malcolm Baldrige National Quality Award Recipient
Premier is a performance improvement alliance of more than 2,500 U.S. hospitals and 81,000-plus other healthcare sites using the power of collaboration to lead the transformation to high quality, cost-effective care. Owned by hospitals, health systems and other providers, Premier maintains the nation's most comprehensive repository of clinical, financial and outcomes information and operates a leading healthcare purchasing network. A world leader in helping deliver measurable improvements in care, Premier has worked with the Centers for Medicare & Medicaid Services and the United Kingdom's National Health Service North West to improve hospital performance. Headquartered in Charlotte, N.C., Premier also has an office in Washington.
About IrriMax Corporation
Founded in 2003, IrriMax Corporation develops and markets irrigation solutions using a patented, innovative delivery method that produces unmatched efficacy and safety. The medical device company’s goal is to improve patient outcomes by treating and preventing infections, as well as to increase the safety of healthcare workers. Its flagship product, IrriSept®, is the first and only FDA-cleared irrigation system containing CHG. Continual innovation and ongoing clinical research guide the development of IrriMax products. For more information, visit www.irrisept.com.
1 Laboratory Testing Records per USP <51>, Antimicrobial Effectiveness Testing, on file at IrriMax Corporation
2 Laboratory Testing Records, “Chlorhexidine Gluconate (CHG) Bacterial Study Report,” on file at IrriMax Corporation
CONTACT:
For IrriMax Corporation
Wetherhead Communications
Debra Patterson: 404-843-8786
[email protected]
KEYWORDS: United States North America Florida
INDUSTRY KEYWORDS: Practice Management Health Medical Devices Managed Care
MEDIA:
| Logo |